Squarepoint’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-594
Closed -$18K 2701
2019
Q4
$18K Sell
594
-149
-20% -$5.54K ﹤0.01% 2428
2019
Q3
$36K Sell
743
-165
-18% -$7.25K ﹤0.01% 2262
2019
Q2
$41K Buy
+908
New +$43K ﹤0.01% 2292
2019
Q1
Sell
-1,113
Closed -$52K 2522
2018
Q4
$52K Buy
1,113
+348
+45% +$40K ﹤0.01% 1843
2018
Q3
$116K Buy
+765
New +$109K ﹤0.01% 1872
2018
Q2
Sell
-215
Closed -$54K 2137
2018
Q1
$54K Buy
+215
New +$59K ﹤0.01% 1609
2017
Q1
Sell
-172
Closed -$35K 2002
2016
Q4
$35K Buy
+172
New +$41K ﹤0.01% 1713
2016
Q1
Sell
-103
Closed -$43K 1511
2015
Q4
$43K Buy
+103
New +$46.1K ﹤0.01% 1195

Other funds holding ACGN

Squarepoint's ACGN Position: Q1 2020 in Review

Squarepoint sold out of Aceragen Inc (ACGN) in Q1 2020, closing a stake of 594 shares — an estimated $18K sold.

Squarepoint first reported a position in ACGN in Q4 2015 and held it in 8 quarters. The position peaked at $116K in Q3 2018. 44 funds tracked by Wall St. Rank hold ACGN as of Q1 2020.

  • Squarepoint reported no remaining Aceragen Inc position as of Q1 2020 after selling out during the quarter.
  • Squarepoint sold 594 Aceragen Inc shares in Q1 2020, an estimated $18K.
  • Squarepoint first reported a position in Aceragen Inc in Q4 2015 and held it in 8 quarters.
  • Squarepoint's Aceragen Inc position peaked at $116K in Q3 2018.
  • 44 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2020.

Based on Squarepoint's 13F filing for Q1 2020, filed 15 May 2020.